Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Clin Invest ; 128(4): 1627-1640, 2018 04 02.
Article in English | MEDLINE | ID: mdl-29553486

ABSTRACT

Apoptosis has been proposed as a key mechanism responsible for CD4+ T cell depletion and immune dysfunction during HIV infection. We demonstrated that Q-VD-OPH, a caspase inhibitor, inhibits spontaneous and activation-induced death of T cells from SIV-infected rhesus macaques (RMs). When administered during the acute phase of infection, Q-VD-OPH was associated with (a) reduced levels of T cell death, (b) preservation of CD4+/CD8+ T cell ratio in lymphoid organs and in the gut, (c) maintenance of memory CD4+ T cells, and (d) increased specific CD4+ T cell response associated with the expression of cytotoxic molecules. Although therapy was limited to the acute phase of infection, Q-VD-OPH-treated RMs showed lower levels of both viral load and cell-associated SIV DNA as compared with control SIV-infected RMs throughout the chronic phase of infection, and prevented the development of AIDS. Overall, our data demonstrate that Q-VD-OPH injection in SIV-infected RMs may represent an adjunctive therapeutic agent to control HIV infection and delaying disease progression to AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Amino Acid Chloromethyl Ketones/pharmacology , Caspase Inhibitors/pharmacology , Quinolines/pharmacology , Simian Acquired Immunodeficiency Syndrome/drug therapy , Simian Immunodeficiency Virus/metabolism , Acquired Immunodeficiency Syndrome/enzymology , Acquired Immunodeficiency Syndrome/pathology , Animals , CD4-CD8 Ratio , CD4-Positive T-Lymphocytes/enzymology , CD4-Positive T-Lymphocytes/pathology , Disease Progression , Female , Lymphocyte Depletion , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/enzymology , Simian Acquired Immunodeficiency Syndrome/pathology
2.
AIDS ; 28(11): 1593-602, 2014 Jul 17.
Article in English | MEDLINE | ID: mdl-24865974

ABSTRACT

OBJECTIVE: Patients coinfected with HIV and Mycobacterium tuberculosis frequently experience a paradoxical worsening of tuberculosis (TB) symptoms early after the initiation of combination antiretroviral therapy (cART). This immune reconstitution inflammatory syndrome (TB-IRIS) can lead to significant morbidity and needs to be distinguished from TB recurrence due to ineffective treatment. We investigated whether plasma biomarkers could predict the occurrence of TB-IRIS. DESIGN: ANRS 129 BKVIR is a single-arm multicentre trial that enrolled 69 cART-naïve HIV-1-infected patients treated for TB. The patients received once-daily tenofovir/emtricitabine/efavirenz first-line regimen. TB-IRIS cases (IRIS+) were validated by an Event Review Committee. METHODS: A panel of 26 plasma biomarkers was monitored longitudinally for 24 weeks from cART initiation onward, using multiplexed assays and high-sensitivity ELISA. Statistical analyses of biomarkers were adjusted for test multiplicity. RESULTS: One-third of patients (n=23) experienced TB-IRIS. The inflammatory cytokines and chemokines interleukin (IL)-6, IL-8, interferon-gamma-induced protein 10 (IP-10), and tumour necrosis factor-alpha (TNF-α) showed increased plasma levels at week 4 in IRIS-positive (IRIS+) patients (P<0.05 for each biomarker). The soluble IL-2 receptor sCD25, which is released upon CD4 T-cell activation, was significantly increased at week 0 in IRIS+ patients (P<0.05), and remained elevated throughout follow-up. IL-7, a key homeostatic cytokine for CD4 T-cells, showed a trend for higher values in the TB-IRIS group. Both sCD25 and IL-7 baseline levels were independently associated with a shorter time to TB-IRIS occurrence (P=0.005 and P=0.02, respectively). CONCLUSION: These findings support a role for CD4 T-cell activation prior to massive inflammation in the development of TB-IRIS.


Subject(s)
Anti-HIV Agents/administration & dosage , Biomarkers/blood , CD4-Positive T-Lymphocytes/immunology , HIV Infections/complications , Immune Reconstitution Inflammatory Syndrome/diagnosis , Lymphocyte Activation , Tuberculosis/immunology , Adenine/administration & dosage , Adenine/adverse effects , Adenine/analogs & derivatives , Adult , Alkynes , Anti-HIV Agents/adverse effects , Benzoxazines/administration & dosage , Benzoxazines/adverse effects , Cyclopropanes , Deoxycytidine/administration & dosage , Deoxycytidine/adverse effects , Deoxycytidine/analogs & derivatives , Emtricitabine , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Mycobacterium tuberculosis/immunology , Organophosphonates/administration & dosage , Organophosphonates/adverse effects , Risk Factors , Tenofovir
3.
J Clin Virol ; 57(1): 70-6, 2013 May.
Article in English | MEDLINE | ID: mdl-23375238

ABSTRACT

BACKGROUND: The Human T-cell Leukemia Virus type 1 (HTLV-1) is the causative agent of several inflammatory diseases, including HTLV-1-associated inflammatory myopathies (HAIM). Little is known about the virological and immunological characteristics of this viral disease. OBJECTIVES: To characterize the histological and virological features of HAIM patients, in order to better understand the pathogenetic mechanisms and unravel new biological markers of this disease. STUDY DESIGN: We conducted a retrospective study on 13 patients with HAIM, based on blood and muscle samples. We included blood samples from HTLV-1-infected individuals without myopathy as controls. Muscle biopsies were used for a broad immunohistological evaluation of tissue damage and inflammation, as well as identification of infected cells through in situ hybridization. DNA extracted from patients' PBMC was used to identify the virus genotype by sequencing and to assess the proviral load by quantitative PCR. Anti-viral antibodies in plasma samples were titrated by indirect immunofluorescence. RESULTS: Patients originate from HTLV-1 endemic areas, the West Indies and West Africa. Histological alterations and inflammation in patients muscles were mostly moderate, with classical features of idiopathic myositis and rare HTLV-1-infected infiltrating cells. In all patients, HTLV-1 belonged to the A subtype, transcontinental subgroup. Anti-HTLV-1 antibodies titers were high, but the proviral load was not elevated compared to asymptomatic HTLV-1 carriers. CONCLUSION: We show here that muscle inflammation is moderate in HAIM, and accompanied by a low HTLV-1 proviral load, suggesting that the pathogenetic events do not exactly mirror those of other HTLV-1-associated inflammatory diseases.


Subject(s)
HTLV-I Infections/virology , Human T-lymphotropic virus 1/isolation & purification , Inflammation/virology , Myositis/virology , Adult , Africa, Western , Aged , Aged, 80 and over , Female , Human T-lymphotropic virus 1/classification , Human T-lymphotropic virus 1/genetics , Humans , Male , Middle Aged , Phylogeny , Proviruses/isolation & purification , RNA, Messenger/analysis , RNA, Viral/analysis , Retrospective Studies , Statistics, Nonparametric , Viral Load , West Indies
4.
PLoS Pathog ; 7(6): e1002087, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21731488

ABSTRACT

Subversion or exacerbation of antigen-presenting cells (APC) death modulates host/pathogen equilibrium. We demonstrated during in vitro differentiation of monocyte-derived macrophages and monocyte-derived dendritic cells (DCs) that HIV sensitizes the cells to undergo apoptosis in response to TRAIL and FasL, respectively. In addition, we found that HIV-1 increased the levels of pro-apoptotic Bax and Bak molecules and decreased the levels of anti-apoptotic Mcl-1 and FLIP proteins. To assess the relevance of these observations in the context of an experimental model of HIV infection, we investigated the death of APC during pathogenic SIV-infection in rhesus macaques (RMs). We demonstrated increased apoptosis, during the acute phase, of both peripheral blood DCs and monocytes (CD14(+)) from SIV(+)RMs, associated with a dysregulation in the balance of pro- and anti-apoptotic molecules. Caspase-inhibitor and death receptors antagonists prevented apoptosis of APCs from SIV(+)RMs. Furthermore, increased levels of FasL in the sera of pathogenic SIV(+)RMs were detected, compared to non-pathogenic SIV infection of African green monkey. We suggest that inappropriate apoptosis of antigen-presenting cells may contribute to dysregulation of cellular immunity early in the process of HIV/SIV infection.


Subject(s)
Apoptosis/immunology , Dendritic Cells/pathology , HIV Infections/pathology , Monocytes/pathology , Simian Acquired Immunodeficiency Syndrome/pathology , Animals , Antigen-Presenting Cells/pathology , Chlorocebus aethiops , Dendritic Cells/immunology , Fas Ligand Protein , HIV Infections/immunology , HIV-1/immunology , Humans , Immunity, Cellular , Macaca mulatta , Monocytes/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , TNF-Related Apoptosis-Inducing Ligand
5.
J Virol ; 84(4): 1838-46, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19939930

ABSTRACT

Divergent Toll-like receptor 7 (TLR7) and TLR9 signaling has been proposed to distinguish pathogenic from nonpathogenic simian immunodeficiency virus infection in primate models. We demonstrate here that increased expression of type I interferon in pathogenic rhesus macaques compared to nonpathogenic African green monkeys was associated with the recruitment of plasmacytoid dendritic cells in the lymph nodes and the presence of an inflammatory environment early after infection, instead of a difference in the TLR7/9 response.


Subject(s)
Dendritic Cells/immunology , Interferon Type I/metabolism , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/immunology , Simian Immunodeficiency Virus/pathogenicity , Acute-Phase Reaction/immunology , Acute-Phase Reaction/pathology , Animals , Cell Movement , Chlorocebus aethiops , Dendritic Cells/pathology , Inflammation/immunology , Inflammation/pathology , Interferon-alpha/metabolism , Interleukin-8/metabolism , Lymph Nodes/immunology , Lymph Nodes/pathology , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/pathology , Species Specificity , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 9/metabolism , Virulence/immunology
6.
J Immunol ; 184(2): 984-92, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-20018630

ABSTRACT

IL-17 is a potent effector cytokine involved in inflammatory response and antimicrobial defense. We report that SIV infection of rhesus macaques (RMs) results in the emergence of IL-17-expressing cells during the acute phase. This subpopulation appears at day 14 postinfection concomitantly with an increase in TGF-beta and IL-18 expression. This subset, which exhibits phenotypic markers of NK T cells (NKT), rather than Th17 CD4 cells, persists during the chronic phase and is higher in noncontrollers SIV-infected RMs compared with controllers SIV-infected RMs. In contrast, in the nonpathogenic model of SIVagm infection of African green monkeys, no change in the level of IL-17-expressing cells is observed in lymphoid organs. Consistent with the emergence of TGF-beta and IL-18 during the acute phase in SIV-infected RMs, but not in SIV-infected African green monkeys, we demonstrate that in vitro TGF-beta and IL-18 induce the differentiation and expansion of IL-17+NKT+. Altogether, these results demonstrate that IL-17-producing NKT are associated with the pathogenesis of SIV in RMs and suggest that TGF-beta and IL-18 play a role in their development.


Subject(s)
Interleukin-17 , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus , T-Lymphocytes, Helper-Inducer/pathology , Animals , Cell Differentiation , Cell Proliferation , Chlorocebus aethiops , Disease Progression , Immunophenotyping , Interleukin-18/biosynthesis , Interleukin-18/physiology , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/pathology , T-Lymphocytes, Helper-Inducer/virology , Transforming Growth Factor beta/biosynthesis , Transforming Growth Factor beta/physiology
7.
Hepatology ; 50(5): 1380-91, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19821533

ABSTRACT

UNLABELLED: Chronic hepatitis B virus (HBV) infection is characterized by functionally impaired T cell responses. To ensure active immunotherapy, the immune response must be switched from exhausted T cells to functional effectors that can attain the liver and cure the viral infection. We thus designed a recombinant HBV (rHBV) containing a modified viral core gene that specifically delivers a foreign antigenic polyepitope to the liver. This recombinant virus could only be self-maintained in hepatocytes already infected by HBV through capsid complementation. A strong foreign epitope-specific T cell response was first primed in the periphery by way of DNA immunization in human leukocyte antigen (HLA)-A2/DR1 transgenic mice. After the hydrodynamic (hyd.) injection of rHBV, expression of the foreign antigenic polyepitope in hepatocytes attracted/reactivated a vigorous T cell response in situ. Most liver-infiltrating CD8(+) T cells proved to be functional effectors. Following DNA priming and hyd. injection, the rHBV-based expression of hepatitis B surface antigen (HBsAg) in mouse liver was almost completely inhibited without causing major liver injury. Studies in HBsAg/HLA-A2/DR1 transgenic mice further validated our approach. CONCLUSION: For the first time, HBV was used as a gene delivery vector, which strongly triggered functional T cell response and subsequently controlled the viral expression in the liver of surrogate mouse models for HBV infection. It might represent an innovative and promising strategy of active immunotherapy during HBV persistent infection. This concept could even be more generally extended to other chronic viral diseases.


Subject(s)
Antigens/metabolism , Gene Expression Regulation, Viral/physiology , Gene Transfer Techniques , Genetic Vectors/genetics , Hepatitis B virus/genetics , T-Lymphocytes/immunology , Animals , Disease Models, Animal , Epitopes/genetics , Female , HLA-A2 Antigen/genetics , HLA-A2 Antigen/metabolism , HLA-DR1 Antigen/genetics , HLA-DR1 Antigen/metabolism , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/metabolism , Hepatitis B virus/physiology , Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/immunology , Hepatitis C, Chronic/pathology , Immunotherapy, Active , Liver/immunology , Liver/pathology , Liver/virology , Mice , Mice, Transgenic , T-Lymphocytes/pathology , Virus Replication/physiology
8.
PLoS Pathog ; 4(11): e1000205, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19008946

ABSTRACT

The blood-brain barrier (BBB), which forms the interface between the blood and the cerebral parenchyma, has been shown to be disrupted during retroviral-associated neuromyelopathies. Human T Lymphotropic Virus (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a slowly progressive neurodegenerative disease associated with BBB breakdown. The BBB is composed of three cell types: endothelial cells, pericytes and astrocytes. Although astrocytes have been shown to be infected by HTLV-1, until now, little was known about the susceptibility of BBB endothelial cells to HTLV-1 infection and the impact of such an infection on BBB function. We first demonstrated that human cerebral endothelial cells express the receptors for HTLV-1 (GLUT-1, Neuropilin-1 and heparan sulfate proteoglycans), both in vitro, in a human cerebral endothelial cell line, and ex vivo, on spinal cord autopsy sections from HAM/TSP and non-infected control cases. In situ hybridization revealed HTLV-1 transcripts associated with the vasculature in HAM/TSP. We were able to confirm that the endothelial cells could be productively infected in vitro by HTLV-1 and that blocking of either HSPGs, Neuropilin 1 or Glut1 inhibits this process. The expression of the tight-junction proteins within the HTLV-1 infected endothelial cells was altered. These cells were no longer able to form a functional barrier, since BBB permeability and lymphocyte passage through the monolayer of endothelial cells were increased. This work constitutes the first report of susceptibility of human cerebral endothelial cells to HTLV-1 infection, with implications for HTLV-1 passage through the BBB and subsequent deregulation of the central nervous system homeostasis. We propose that the susceptibility of cerebral endothelial cells to retroviral infection and subsequent BBB dysfunction is an important aspect of HAM/TSP pathogenesis and should be considered in the design of future therapeutics strategies.


Subject(s)
Blood-Brain Barrier/pathology , Blood-Brain Barrier/virology , Human T-lymphotropic virus 1 , Paraparesis, Tropical Spastic/pathology , Retroviridae Infections/pathology , Autopsy , Cell Line , Endothelial Cells/pathology , Endothelial Cells/virology , Humans , Receptors, Virus/analysis , Spinal Cord/pathology , Tight Junctions/pathology , Tight Junctions/virology
9.
Immunobiology ; 212(3): 167-77, 2007.
Article in English | MEDLINE | ID: mdl-17412284

ABSTRACT

Interactions between thymic dendritic cells (DC) and thymocytes are critical for proper development of T-cells. We identified human thymic DC populations on the basis of CD123, CD11c and CD14 expression. High levels of CD123 (IL-3R) and CD45RA defined the plasmacytoid DC (pDC) subset. Human thymic CD11c(+) DC expressed CD45RO and myeloid-related markers (CD13, CD33 and CD11b). CD11c(+) DC could be separated into two main subsets based on differential expression of CD14: CD11c(+) CD14(-) and CD11c(+) CD14(+) cells. Spontaneous production of IL-10 and IFNgamma without exogenous stimulation, was observed in the three DC subsets. Important phenotype modifications were observed in pDC cultures supplemented with IL-3. A down-regulation of CD123 and appearance of myeloid markers such as CD11b and CD11c on CD45RA(+) cells was noticed within the first 48h; at a later time there was a shift from CD45RA to CD45RO expression, as well as appearance of CD14 expression. CD11c(+) cells emerging in pDC culture did not express high levels of HLA-DR, CD83 and co-stimulatory molecules. This suggests an in vitro evolution of human thymic pDC toward a myeloid phenotype found in the CD11c(+) subset of thymic DC.


Subject(s)
Dendritic Cells/classification , Dendritic Cells/immunology , Immunophenotyping , Thymus Gland/cytology , Antigens, CD/biosynthesis , Cells, Cultured , Child, Preschool , Cytokines/biosynthesis , Dendritic Cells/metabolism , Humans , Infant , Infant, Newborn , Thymus Gland/immunology , Thymus Gland/metabolism
10.
J Immunol ; 177(10): 6685-94, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-17082581

ABSTRACT

Immunological and virological events that occur during the earliest stages of SIV infection are now considered to have a major impact on subsequent disease progression. In the present study, we demonstrate a clear correlation between progression to AIDS and the rate of in vitro CD4+ (but not CD8+) T cell death in lymph nodes. The dying CD4+ T cells were effector memory T cells, which are critical for the immune response to pathogens. However, there was no correlation between the rate of the viral replication within lymph nodes and the extent of Fas ligand-mediated death, despite the increased sensitivity of CD4+ T cells to death in response to recombinant human Fas ligand. CD4+ T cell death was caspase and apoptosis-inducing factor independent but was clearly associated with mitochondrion damage. Interestingly, higher expression levels of the active form of Bak, a proapoptotic molecule involved in mitochondrial membrane permeabilization, were observed in SIV-infected macaques progressing more rapidly to AIDS. Finally, we demonstrated that the strain of SIV we used requires CCR5 and BOB/GRP15 molecules as coreceptors and caused death of unstimulated noncycling primary CD4+ T cells. Altogether, these results demonstrate that CD4+ T cell death occurring early after SIV infection is a crucial determinant of progression to AIDS and that it is mediated by the intrinsic death pathway.


Subject(s)
CD4-Positive T-Lymphocytes/pathology , Lymph Nodes/immunology , Lymph Nodes/pathology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/pathology , Simian Immunodeficiency Virus/immunology , Animals , Apoptosis Inducing Factor/physiology , CD4-Positive T-Lymphocytes/enzymology , CD4-Positive T-Lymphocytes/virology , Caspase Inhibitors , Caspases/metabolism , Caspases/physiology , Cell Death/immunology , Cells, Cultured , Disease Progression , Lymph Nodes/virology , Lymphocyte Count , Macaca mulatta , Membrane Potentials/immunology , Mitochondrial Membranes/enzymology , Mitochondrial Membranes/immunology , Mitochondrial Membranes/pathology , Predictive Value of Tests , Simian Acquired Immunodeficiency Syndrome/enzymology , fas Receptor/biosynthesis
11.
AIDS ; 20(4): 533-42, 2006 Feb 28.
Article in English | MEDLINE | ID: mdl-16470117

ABSTRACT

OBJECTIVES: Human thymus can be infected by HIV-1 with potential consequences on immune regeneration and homeostasis. We previously showed that CD4 thymocytes preferentially replicate CXCR4 tropic (X4) HIV-1 dependently on interleukin (IL)-7. Here we addressed the susceptibility of thymic dendritic cells (DC) to HIV-1 infection. METHODS: We investigated the replication ability of CXCR4 or CCR5 (R5) tropic HIV-1 in thymic micro-explants as well as in isolated thymic CD11clowCD14- DC, CD11chighCD14+ DC and plasmacytoid DC subsets. RESULTS: Thymic tissue was productively infected by both X4 and R5 viruses. However, X4 but not R5 HIV-1 replication was enhanced by IL-7 in thymic micro-explants, suggesting that R5 virus replication occurred in cells other than thymocytes. Indeed, we found that R5 HIV-1 replicated efficiently in DC isolated from thymic tissue. The replicative capacity of X4 and R5 viruses differed according to the different DC subsets. R5 but not X4 HIV-1 efficiently replicated in CD11chighCD14+ DC. In contrast, no HIV-1 replication was detected in CD11clowCD14- DC. Both X4 and R5 viruses efficiently replicated in plasmacytoid DC, which secreted interferon-alpha upon HIV-1 exposure. Productive HIV-1 infection also caused DC loss, consistent with different permissivity of each DC subset. CONCLUSIONS: Thymic DC sustain high levels of HIV-1 replication. DC might thus be the first target for R5 HIV-1 infection of thymus, acting as a Trojan horse for HIV-1 spread to thymocytes. Furthermore, DC death induced by HIV-1 infection may affect thymopoiesis.


Subject(s)
Dendritic Cells/virology , HIV Infections/virology , HIV-1/physiology , Thymus Gland/virology , Dendritic Cells/metabolism , Disease Susceptibility/pathology , Disease Susceptibility/virology , HIV Infections/metabolism , Humans , Interferon-alpha/metabolism , Receptors, CCR5/metabolism , Receptors, CXCR4/metabolism , Thymus Gland/pathology , Virus Replication/physiology
12.
J Immunol ; 174(11): 6898-908, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15905532

ABSTRACT

Immunological and virological events that occur during the earliest stages of HIV-1 infection are now considered to have a major impact on subsequent disease progression. We observed changes in the frequencies of CD8(bright) T cells expressing different chemokine receptors in the peripheral blood and lymph nodes of rhesus macaques during the acute phase of the pathogenic SIVmac251 infection; the frequency of CD8(bright) T cells expressing CXCR4 decreased, while the frequency of those expressing CCR5 increased. These reciprocal changes in chemokine receptor expression were associated with changes in the proportion of cycling (Ki67(+)) CD8(bright) T cells, and with the pattern of CD8(bright) T cell differentiation as defined by expression of CCR7 and CD45RA. In contrast, during the primary phase of the attenuated SIVmac251Deltanef infection, no major change was observed. Whereas during the acute phase of the infection with pathogenic SIV (2 wk postinfection) no correlate of disease protection was identified, once the viral load set points were established (2 mo postinfection), we found that the levels of cycling and of CCR5- and CXCR4-positive CD8(bright) T cells were correlated with the extent of viral replication and therefore with SIV-infection outcome. Our data reveal that, during primary SIV infection, despite intense CD8 T cell activation and an increase in CCR5 expression, which are considered as essential for optimal effector function of CD8(+) T cells, these changes are associated with a poor prognosis for disease progression to AIDS.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/virology , Cell Differentiation/immunology , Cytotoxicity, Immunologic/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/immunology , Virus Replication/immunology , Acute Disease , Animals , CD4 Lymphocyte Count , CD4-CD8 Ratio , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/pathology , Disease Progression , Female , Ki-67 Antigen/biosynthesis , Ki-67 Antigen/blood , Lymphocyte Activation/immunology , Macaca mulatta , Male , Receptors, CCR5/biosynthesis , Receptors, CCR5/blood , Receptors, CCR7 , Receptors, CXCR4/biosynthesis , Receptors, CXCR4/blood , Receptors, Chemokine/biosynthesis , Receptors, Chemokine/blood , Simian Acquired Immunodeficiency Syndrome/pathology , Simian Immunodeficiency Virus/physiology
13.
AIDS ; 19(7): 663-73, 2005 Apr 29.
Article in English | MEDLINE | ID: mdl-15821392

ABSTRACT

BACKGROUND: An attenuated immunodeficiency virus has been long considered innocuous. Nevertheless, converging data suggest that low levels of viral replication can still provoke AIDS. Pathogenesis of these attenuated infections is not understood. OBJECTIVES: To determine the pathogenicity of a long-term attenuated infection and to delineate T-cell dynamics during such an infection. METHODS: This is a cross-sectional study of 12 rhesus macaques infected with SIV Delta nef for 8 years. We evaluated apoptosis (annexin V), activation (HLA-DR, Ki67), and newly generated T cells (TCR excision circle: TREC). RESULTS: Infection with SIV Delta nef induced pathological CD4 T-cell depletion after 8 years of infection. Virus replication and CD8 T-cell activation positively correlated with the rate of disease progression. The frequency of TREC within CD8+CD45RA+ cells increased in SIV Delta nef-infected animals compared to age-matched non-infected controls. Moreover, in the cohort of infected animals, TREC+CD45RA+CD4+ T-cell counts correlated strongly with non-progression to AIDS. The animal with the lowest rate of disease progression exhibited a 115-fold increase in TREC+CD45RA+CD4+ T-cell counts compared to age-matched non-infected controls. In contrast, the animal showing the fastest rate of progression to AIDS displayed 600-fold lower TREC+CD45RA+CD4+ T-cell counts compared to age-matched non-infected controls. CONCLUSIONS: Our results suggest that the thymus plays a major role in the pathogenesis of an attenuated SIV infection and that a sustained thymic output could maintain CD4 T-cell homeostasis in the context of low viral loads.


Subject(s)
Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/physiology , Animals , Apoptosis , CD4 Lymphocyte Count , CD4-CD8 Ratio , CD8-Positive T-Lymphocytes , Cell Proliferation , Disease Progression , Gene Products, nef , Gene Rearrangement, T-Lymphocyte , Leukocyte Common Antigens/analysis , Lymphocyte Activation , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/immunology , Time Factors , Viral Load , Virus Replication
14.
J Virol ; 78(3): 1080-92, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14722263

ABSTRACT

Among the many simian immunodeficiency virus (SIV) immunogens, only live attenuated viral vaccines have afforded strong protection to a natural pathogenic isolate. Since the promoter is crucial to the tempo of viral replication in general, it was reasoned that promoter exchange might confer a novel means of attenuating SIV. The core enhancer and promoter sequences of the SIV macaque 239nefstop strain (NF-kappaB/Sp1 region from -114 bp to mRNA start) have been exchanged for those of the human cytomegalovirus immediate-early promoter (CMV-IE; from -525 bp to mRNA start). During culture of the resulting virus, referred to as SIVmegalo, on CEMx174 or rhesus macaque peripheral blood mononuclear cells, deletions arose in distal regions of the CMV-IE sequences that stabilized after 1 or 2 months of culture. However, when the undeleted form of SIVmegalo was inoculated into rhesus macaques, animals showed highly controlled viremia during primary and persistent infection. Compared to parental virus infection in macaques, primary viremia was reduced by >1,000-fold to undetectable levels, with little sign of an increase of cycling cells in lymph nodes, CD4(+) depletion, or altered T-cell activation markers in peripheral blood. Moreover, in contrast to wild-type infection in most infected animals, the nef stop mutation did not revert to the wild-type codon, indicating yet again that replication was dramatically curtailed. Despite such drastic attenuation, antibody titers and enzyme-linked immunospot reactivity to SIV peptides, although slower to appear, were comparable to those seen in a parental virus infection. When animals were challenged intravenously at 4 or 6 months with the uncloned pathogenic SIVmac251 strain, viremia was curtailed by approximately 1,000-fold at peak height without any sign of hyperactivation in CD4(+)- or CD8(+)-T-cell compartment or increase in lymph node cell cycling. To date, there has been a general inverse correlation between attenuation and protection; however, these findings show that promoter exchange constitutes a novel means to highly attenuate SIV while retaining the capacity to protect against challenge virus.


Subject(s)
Immediate-Early Proteins/immunology , Promoter Regions, Genetic/genetics , Recombinant Fusion Proteins/immunology , Simian Acquired Immunodeficiency Syndrome/prevention & control , Simian Immunodeficiency Virus/pathogenicity , Vaccines, Attenuated/administration & dosage , AIDS Vaccines/administration & dosage , AIDS Vaccines/immunology , Animals , Base Sequence , Cytomegalovirus/genetics , Humans , Immediate-Early Proteins/genetics , Immediate-Early Proteins/metabolism , Macaca mulatta , Molecular Sequence Data , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , SAIDS Vaccines/administration & dosage , SAIDS Vaccines/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/immunology , Terminal Repeat Sequences/genetics , Vaccines, Attenuated/immunology , Viremia/immunology , Viremia/prevention & control , Virus Replication
15.
J Immunol ; 171(8): 4447-53, 2003 Oct 15.
Article in English | MEDLINE | ID: mdl-14530372

ABSTRACT

The main failure of antiretroviral therapy is the lack of restoration of HIV-specific CD4(+) T cells. IL-7, which has been shown to be a crucial cytokine for thymopoiesis, has been envisaged as an additive therapeutic strategy. However, in vitro studies suggest that IL-7 might sustain HIV replication in thymocytes and T lymphocytes. Therefore, in the present study, we evaluated the effect of IL-7 on both T cell renewal and viral load in SIVmac-infected young macaques in the absence of antiretroviral therapy. This evaluation was conducted during the asymptomatic phase in view of a potential treatment of HIV patients. We show that IL-7 induces both a central renewal and a peripheral expansion of T lymphocytes associated with cell activation. No alarming modulation of the other hemopoietic cells was observed. No increase in the viral load was shown in blood or lymph nodes. These data strengthen the rationale for the use of IL-7 as an efficient immunotherapy in AIDS.


Subject(s)
Interleukin-7/administration & dosage , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/physiology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , Virus Replication/immunology , Animals , CD4-CD8 Ratio , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Division/immunology , Dose-Response Relationship, Immunologic , Down-Regulation/immunology , Drug Evaluation, Preclinical , Gene Rearrangement, T-Lymphocyte/immunology , Hematopoiesis/immunology , Humans , Interleukin-7/physiology , Interphase/immunology , Lymph Nodes/immunology , Lymph Nodes/virology , Lymphocyte Activation/immunology , Macaca mulatta , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Simian Acquired Immunodeficiency Syndrome/blood , Simian Acquired Immunodeficiency Syndrome/metabolism , Simian Immunodeficiency Virus/immunology , T-Lymphocyte Subsets/metabolism , Up-Regulation/immunology , Viral Load
16.
AIDS ; 17(11): 1585-96, 2003 Jul 25.
Article in English | MEDLINE | ID: mdl-12853740

ABSTRACT

OBJECTIVE: The acute phase of HIV and SIV infections leads to a host/virus equilibrium, and accumulating evidence suggests that this early phase dictates further progression towards AIDS. To gain insight into the early events that determine rapid disease progression, we performed a longitudinal study in the SIV rhesus macaque model, allowing an in-depth analysis of the primary stage of infection. METHODS: We assessed viral replication (quantification of replicating and infected cells in lymph nodes, plasma viral load), immune response (cytotoxic T lymphocyte, antibody, proliferative responses), apoptosis and cycling cells (Ki-67 labelling) on lymph nodes and blood in nine rhesus macaques infected with the pathogenic SIVmac251 isolate. RESULTS: Six primates remained asymptomatic during the one year follow-up period of the study, whereas three developed AIDS within 5-6 months. During the first 2 weeks of infection, peak numbers of apoptotic cells in the lymph node T-cell areas were significantly higher in the three future rapid progressors than in the six future slow progressors, and were correlated with subsequent viraemia levels measured 6 months after infection. The numbers of infected or cycling cells in the same lymph node T-cell areas, however, only became significantly different in future rapid and slow progressors 8 weeks after infection, at the end of the primary phase. CONCLUSION: Our findings identified extensive apoptosis induction in peripheral lymphoid organs as an early and predictive event that may play a crucial role in impairing the capacity of the immune system to control viral replication and progression towards disease.


Subject(s)
Lymph Nodes/virology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/physiology , Acute Disease , Animals , Apoptosis , Biomarkers/analysis , Cell Cycle , Cell Division , Disease Progression , Ki-67 Antigen/analysis , Lymph Nodes/pathology , Macaca mulatta , T-Lymphocytes, Cytotoxic/immunology , Viremia , Virus Replication
17.
AIDS Res Hum Retroviruses ; 19(4): 267-74, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12804002

ABSTRACT

We assessed the possible role in vivo CD4(+) CD8(+) T cells as a viral reservoir for simian immunodeficiency virus (SIV), in a macaque with 50% CD4(+) CD8(+) T cells in peripheral blood. During primary infection (day 14) of this rhesus macaque with the pathogenic SIVmac251 strain, proviruses were detected at similar frequencies in CD4(+) CD8(+) T cells (1/10) and CD4(+) T cells (1/10) and at a lower frequency in CD8(+) T cells (1/800). On day 235, no viral DNA was detected in CD8(+) cells, despite the persistent high viral load, indicating that CD8(+) cells do not constitute a reservoir during the chronic phase of SIV infection. Infection induced early lymphopenia of CD4(+), CD4(+) CD8(+), and CD8(+) cells; only the CD8(+) cell population returned to initial levels and expanded further. We found that CD4(+) CD8(+) T cells expressed the costimulatory CD28 molecule less and were more prone to die in vitro after phytohemagglutinin/interleukin 2 stimulation than were CD4(+) T cells. Taken together, massive death of CD4(+) CD8(+) T cells during acute stages of SIV infection may explain why CD8(+) T cells did not represent a major reservoir for SIV at the onset of infection.


Subject(s)
CD4-Positive T-Lymphocytes/virology , CD8-Positive T-Lymphocytes/virology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/physiology , Animals , CD4-CD8 Ratio , DNA, Viral/blood , Flow Cytometry , Lymphocyte Activation , Lymphocyte Count , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...